Pregnancy and IBD 

Saturday, November 14, 2020

8:10 am - 8:40 am

Uma Mahadevan, MD 

Professor of Medicine
University of California, San Francisco
UCSF Center for Colitis and Crohn's Disease
San Francisco, California

Uma Mahadevan completed a medical degree at the State University of New York in Brooklyn. She completed a residency in internal medicine at Mount Sinai Medical Center in New York, a fellowship in gastroenterology at the University of California, San Francisco (UCSF) and a fellowship in inflammatory bowel disease (IBD) at the Mayo Clinic in Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF, Clinical Services Chief for Gastroenterology, and Co-Director of the UCSF Center for Colitis and Crohn’s Disease and Director of the IBD Fellowship. 

Certified by the American Board of Internal Medicine as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she is a Chair for the Clinical Immunology, Microbiology and Inflammatory Bowel Disease (IMIBD) Section and Chair of the AGA National IBD Parenthood initiative. She is a Fellow of the American College of Gastroenterology and serves on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee.  She is currently Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of their National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress.

Dr. Mahadevan is a special section editor for the journal Gastroenterology and an editorial board member and reviewer for several journals. Dr. Mahadevan has published original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Gut along with several book chapters.  

Dr. Mahadevan specializes in the treatment of ulcerative colitis, Crohn’s disease, and pouchitis. She has a particular interest in pregnancy and fertility in IBD, as well as in clinical trials of experimental therapy for both ulcerative colitis and Crohn’s disease. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and the impact of nutritional interventions in the management of IBD.

Presentation Overview:

Among patients with IBD, approximately 50% are women and most will carry the diagnosis during their fertile years.  This talk will review the management of this population prior to conception, during pregnancy and in the post-partum period.  A recent Clinical Care Pathway will be reviewed as well as the most updated medication safety data.